Skip to main content

Articles

Page 63 of 70

  1. Melanoma and renal cell carcinoma (RCC) are traditionally considered less radioresponsive than other histologies. Whereas stereotactic body radiation therapy (SBRT) involves radiation dose intensification via ...

    Authors: Michelle A Stinauer, Brian D Kavanagh, Tracey E Schefter, Rene Gonzalez, Thomas Flaig, Karl Lewis, William Robinson, Mark Chidel, Michael Glode and David Raben
    Citation: Radiation Oncology 2011 6:34
  2. Radiotherapists are highly interested in optimizing doses especially for patients who tend to suffer from side effects of radiotherapy (RT). It seems to be helpful to identify radiosensitive individuals before...

    Authors: Reinhard Huber, Herbert Braselmann, Hans Geinitz, Irene Jaehnert, Adolf Baumgartner, Reinhard Thamm, Markus Figel, Michael Molls and Horst Zitzelsberger
    Citation: Radiation Oncology 2011 6:32
  3. The study of lung parenchyma anatomical modification is useful to estimate dose discrepancies during the radiation treatment of Non-Small-Cell Lung Cancer (NSCLC) patients. We propose and validate a method, ba...

    Authors: Elena Faggiano, Giovanni M Cattaneo, Cristina Ciavarro, Italo Dell'Oca, Diego Persano, Riccardo Calandrino and Giovanna Rizzo
    Citation: Radiation Oncology 2011 6:31
  4. To evaluate feasibility and toxicity of carbon ion therapy for treatment of sinonasal malignancies. First site of treatment failure in malignant tumours of the paranasal sinuses and nasal cavity is mostly in-f...

    Authors: Alexandra D Jensen, Anna V Nikoghosyan, Swantje Ecker, Malte Ellerbrock, Jürgen Debus and Marc W Münter
    Citation: Radiation Oncology 2011 6:30
  5. MicroRNAs are regulators of central cellular processes and are implicated in the pathogenesis and prognosis of human cancers. MicroRNAs also modulate responses to anti-cancer therapy. In the context of radiati...

    Authors: Olivier M Niemoeller, Maximilian Niyazi, Stefanie Corradini, Franz Zehentmayr, Minglun Li, Kirsten Lauber and Claus Belka
    Citation: Radiation Oncology 2011 6:29
  6. We aimed to evaluate retrospectively the correlation of loco-regional relapse (LRR) rate, distant metastasis (DM) rate, disease free survival (DFS) and overall survival (OS) in a group of breast cancer (BC) pa...

    Authors: Rusen Cosar, Cem Uzal, Fusun Tokatli, Bengu Denizli, Mert Saynak, Nesrin Turan, Sernaz Uzunoglu, Alaattin Ozen, Atakan Sezer, Kamuran Ibis, Burcu Uregen, Vuslat Yurut-Caloglu and Zafer Kocak
    Citation: Radiation Oncology 2011 6:28
  7. This study evaluates the dose distribution of reversed planned tangential beam intensity modulated radiotherapy (IMRT) compared to standard wedged tangential beam three-dimensionally planned conformal radiothe...

    Authors: Volker Rudat, Abdul Aziz Alaradi, Adel Mohamed, Khaled AI-Yahya and Saleh Altuwaijri
    Citation: Radiation Oncology 2011 6:26
  8. There is little data on the safety of combining radiation therapy and human immunodeficiency virus (HIV) protease inhibitors to treat cancers in HIV-positive patients. We describe acute toxicities observed in ...

    Authors: Alfred P See, Jing Zeng, Phuoc T Tran and Michael Lim
    Citation: Radiation Oncology 2011 6:25
  9. Prognostic indexes are useful to guide tailored treatment strategies for cancer patients with brain metastasis (BM). We evaluated the new Graded Prognostic Assessment (GPA) scale in a prospective validation st...

    Authors: Salvador Villà, Damien C Weber, Cristina Moretones, Anabel Mañes, Christophe Combescure, Josep Jové, Paloma Puyalto, Patricia Cuadras, Jordi Bruna, Eugènia Verger, Carme Balañà and Francesc Graus
    Citation: Radiation Oncology 2011 6:23
  10. To report our experience with intensity-modulated or stereotactic reirradiation in patients suffering from recurrent nasopharyngeal carcinoma

    Authors: Falk Roeder, Felix Zwicker, Ladan Saleh-Ebrahimi, Carmen Timke, Christian Thieke, Marc Bischof, Juergen Debus and Peter E Huber
    Citation: Radiation Oncology 2011 6:22
  11. To verify the dose distribution and number of monitor units (MU) for dynamic treatment techniques like volumetric modulated single arc radiation therapy - Rapid Arc - each patient treatment plan has to be veri...

    Authors: Daniela Wagner and Hilke Vorwerk
    Citation: Radiation Oncology 2011 6:21
  12. Recent developments enable to deliver rotational IMRT with standard C-arm gantry based linear accelerators. This upcoming treatment technique was benchmarked in a multi-center treatment planning study against ...

    Authors: Tilo Wiezorek, Tim Brachwitz, Dietmar Georg, Eyck Blank, Irina Fotina, Gregor Habl, Matthias Kretschmer, Gerd Lutters, Henning Salz, Kai Schubert, Daniela Wagner and Thomas G Wendt
    Citation: Radiation Oncology 2011 6:20
  13. Sensorineural hearing loss (SNHL) is one of the major long term side effects from radiation therapy (RT) in nasopharyngeal cancer (NPC) patients. This study aims to review the incidences of SNHL when treating ...

    Authors: Janjira Petsuksiri, Achariyaporn Sermsree, Kullathorn Thephamongkhol, Phawin Keskool, Kanthong Thongyai, Yaowalak Chansilpa and Pittayapoom Pattaranutaporn
    Citation: Radiation Oncology 2011 6:19
  14. This phase I study investigates the feasibility of carboplatin plus dose-dense (q2-week) pemetrexed given concurrently with radiotherapy (XRT) for locally advanced and oligometastatic non-small cell lung cance...

    Authors: Xinglei Shen, Albert DeNittis, Maria Werner-Wasik, Rita Axelrod, Paul Gilman, Thomas Meyer, Joseph Treat, Walter J Curran and Mitchell Machtay
    Citation: Radiation Oncology 2011 6:17
  15. Anaplastic thyroid carcinoma (ATC) is a rare, aggressive malignancy, which is known to metastasize to the heart. We report a case of a patient with ATC with metastatic involvement of the pacemaker leads within...

    Authors: Tina Dasgupta, Igor J Barani and Mack Roach III
    Citation: Radiation Oncology 2011 6:16
  16. The protein kinase CK2 sustains multiple pro-survival functions in cellular DNA damage response and its level is tightly regulated in normal cells but elevated in cancers. Because CK2 is thus considered as pot...

    Authors: Felix Zwicker, Maren Ebert, Peter E Huber, Jürgen Debus and Klaus-Josef Weber
    Citation: Radiation Oncology 2011 6:15
  17. Ameloblastic carcinomas are rare odontogenic tumors. Treatment usually consists of surgical resection and sometimes adjuvant radiation. We report the case of a 71 year-old male patient undergoing carbon ion th...

    Authors: Alexandra D Jensen, Swantje Ecker, Malte Ellerbrock, Anna Nikoghosyan, Jürgen Debus and Marc W Münter
    Citation: Radiation Oncology 2011 6:13
  18. To analyze the outcome after adjuvant radiation therapy with standard fractionation regimen in metastatic lymph nodes (LN) from cutaneous melanoma.

    Authors: Jean-Emmanuel Bibault, Sylvain Dewas, Xavier Mirabel, Laurent Mortier, Nicolas Penel, Luc Vanseymortier and Eric Lartigau
    Citation: Radiation Oncology 2011 6:12
  19. The IAEA held the International Conference on Advances in Radiation Oncology (ICARO) in Vienna on 27-29 April 2009. The Conference dealt with the issues and requirements posed by the transition from convention...

    Authors: Eeva K Salminen, Krystyna Kiel, Geoffrey S Ibbott, Michael C Joiner, Eduardo Rosenblatt, Eduardo Zubizarreta, Jan Wondergem and Ahmed Meghzifene
    Citation: Radiation Oncology 2011 6:11
  20. To assess inter-observer variability in delineating target volume and organs at risk in benign tumor adjacent to optic tract as a quality assurance exercise.

    Authors: Hideya Yamazaki, Hiroya Shiomi, Takuji Tsubokura, Naohiro Kodani, Takuya Nishimura, Norihiro Aibe, Hiroki Udono, Manabu Nishikata, Yoshimi Baba, Mikio Ogita, Koichi Yamashita and Tadayuki Kotsuma
    Citation: Radiation Oncology 2011 6:10
  21. Boron neutron capture therapy (BNCT) is a cell-selective radiation therapy that uses the alpha particles and lithium nuclei produced by the boron neutron capture reaction. BNCT is a relatively safe tool for tr...

    Authors: Hitoshi Fujii, Akifumi Matsuyama, Hiroshi Komoda, Masao Sasai, Minoru Suzuki, Tomoyuki Asano, Yuichiro Doki, Mitsunori Kirihata, Koji Ono, Yasuhiko Tabata, Yasufumi Kaneda, Yoshiki Sawa and Chun Man Lee
    Citation: Radiation Oncology 2011 6:8
  22. 1-{4-[Bis(2-chloroethyl)amino]phenyl}-3-[2-methyl-5-(4-methylacridin-9-ylamino)phenyl]urea (BO-1051) is an N-mustard DNA alkylating agent reported to exhibit antitumor activity. Here we further investigate the...

    Authors: Pei-Ming Chu, Shih-Hwa Chiou, Tsann-Long Su, Yi-Jang Lee, Li-Hsin Chen, Yi-Wei Chen, Sang-Hue Yen, Ming-Teh Chen, Ming-Hsiung Chen, Yang-Hsin Shih, Pang-Hsien Tu and Hsin-I Ma
    Citation: Radiation Oncology 2011 6:7
  23. Radiation-induced DNA double-strand break (DSB) repair can be tested by using pulsed-field gel electrophoresis (PFGE) in agarose-encapsulated cells. However, previous studies have reported that this assay is i...

    Authors: Josep Balart, Gemma Pueyo, Lara I de Llobet, Marta Baro, Xavi Sole, Susanna Marin, Oriol Casanovas, Ricard Mesia and Gabriel Capella
    Citation: Radiation Oncology 2011 6:6
  24. Breast cancers are more frequently diagnosed at an early stage and currently have improved long term outcomes. Late normal tissue complications induced by adjuvant radiotherapy like secondary cancers or cardio...

    Authors: Jean-Philippe Pignol, Brian M Keller and Ananth Ravi
    Citation: Radiation Oncology 2011 6:5
  25. High-precision radiation therapy techniques such as IMRT or sterotactic radiosurgery, delivers more complex treatment fields than conventional techniques. The increased complexity causes longer dose delivery t...

    Authors: Xin Wang, Xiao-Peng Xiong, Jiade Lu, Guo-Pei Zhu, Shao-Qin He, Chao-Su Hu and Hong-Mei Ying
    Citation: Radiation Oncology 2011 6:4
  26. Surgical resection followed by radiotherapy and temozolomide in newly diagnosed glioblastoma can prolong survival, but it is not curative. For patients with disease progression after frontline therapy, there i...

    Authors: Kathryn Beal, Lauren E Abrey and Philip H Gutin
    Citation: Radiation Oncology 2011 6:2
  27. To evaluate the objective and subjective long term swallowing function, and to relate dysphagia to the radiation dose delivered to the critical anatomical structures in head and neck cancer patients treated wi...

    Authors: Evangelia Peponi, Christoph Glanzmann, Bettina Willi, Gerhard Huber and Gabriela Studer
    Citation: Radiation Oncology 2011 6:1
  28. To evaluate the effectivity of fractionated radiotherapy in adolescent and adult patients with pineal parenchymal tumors (PPT).

    Authors: Eva Maria Stoiber, Benjamin Schaible, Klaus Herfarth, Daniela Schulz-Ertner, Peter E Huber, Jürgen Debus and Susanne Oertel
    Citation: Radiation Oncology 2010 5:122
  29. Chemo-radiotherapy offers an alternative to primary surgery and adjuvant therapy for the management of locally advanced stage IV squamous cell carcinomas of the tonsil.

    Authors: Robin J D Prestwich, Kiran Kancherla, Didem Colpan Oksuz, Deborah Williamson, Karen E Dyker, Catherine Coyle and Mehmet Sen
    Citation: Radiation Oncology 2010 5:121
  30. This paper compares the calculated dose to target and normal tissues when using pencil beam (PBC), superposition/convolution (AAA) and Monte Carlo (MC) algorithms for whole breast (WBI) and accelerated partial...

    Authors: Parminder S Basran, Sergei Zavgorodni, Tanya Berrang, Ivo A Olivotto and Wayne Beckham
    Citation: Radiation Oncology 2010 5:120
  31. We aim to investigate the possibility of using 18F-positron emission tomography/computer tomography (PET-CT) to predict the histopathologic response in locally advanced rectal cancer (LARC) treated with preope...

    Authors: Pablo Palma, Raquel Conde-Muíño, Antonio Rodríguez-Fernández, Inmaculada Segura-Jiménez, Rocío Sánchez-Sánchez, Javier Martín-Cano, Manuel Gómez-Río, José A Ferrón and José M Llamas-Elvira
    Citation: Radiation Oncology 2010 5:119
  32. Adjuvant therapy for T3N0 rectal cancer was controversial with respect to both radiation and the use of a combined regimen of chemotherapy. We evaluated both clinical features and biomarkers and sought to dete...

    Authors: Ji Zhu, Ye Xu, Weilie Gu, Junjie Peng, Gang Cai, Guoxiang Cai, Wenjie Sun, Weiqi Shen, Sanjun Cai and Zhen Zhang
    Citation: Radiation Oncology 2010 5:118
  33. This retrospective analysis reports on the comparative outcome of acute gastrointestinal (GI) and genitourinary (GU) toxicities between conformal radiation therapy (CRT) and intensity modulated radiation thera...

    Authors: Robson Ferrigno, Adriana Santos, Lidiane C Martins, Eduardo Weltman, Michael J Chen, Roberto Sakuraba, Cleverson P Lopes and José C Cruz
    Citation: Radiation Oncology 2010 5:117
  34. To examine the role of brachytherapy for aged patients 80 or more in the trend of rapidly increasing number.

    Authors: Hideya Yamazaki, Ken Yoshida, Tadayuki Kotsuma, Yasuo Yoshioka, Masahiko Koizumi, Souhei Furukawa, Naoya Kakimoto, Kimishige Shimizutani and Tsunehiko Nishimura
    Citation: Radiation Oncology 2010 5:116
  35. Intensity-modulated radiotherapy (IMRT) may allow improvement in plan quality for treatment of liver cancer, however increasing radiation modulation complexity can lead to increased uncertainties and requireme...

    Authors: Mark T Lee, Thomas G Purdie, Cynthia L Eccles, Michael B Sharpe and Laura A Dawson
    Citation: Radiation Oncology 2010 5:115
  36. Intracranial malignant peripheral nerve sheath tumors are rare entities that carry a poor prognosis. To date, there are no established therapeutic strategies for these tumors.

    Authors: Konstantinos Gousias, Jan Boström, Attila Kovacs, Pitt Niehusmann, Ingo Wagner and Rudolf Kristof
    Citation: Radiation Oncology 2010 5:114
  37. A variety of hypofractionated radiotherapy schedules has been proposed after breast conserving surgery in the attempt to shorten the overall treatment time. The aim of the present study is to assess acute and ...

    Authors: Letizia Deantonio, Giuseppina Gambaro, Debora Beldì, Laura Masini, Sara Tunesi, Corrado Magnani and Marco Krengli
    Citation: Radiation Oncology 2010 5:112
  38. Radiation therapy after lumpectomy is a standard part of breast conserving therapy for invasive breast carcinoma. The most frequently used schedule worldwide is 60 Gy in 30 fractions in 6 weeks, a time commitm...

    Authors: Marina Guenzi, Stefano Vagge, Ngwa Che Azinwi, Alessia D'Alonzo, Liliana Belgioia, Stefania Garelli, Marco Gusinu and Renzo Corvò
    Citation: Radiation Oncology 2010 5:111
  39. Several comparison studies have shown the capability of VMAT to achieve similar or better plan quality as IMRT, while reducing the treatment time. The experience of VMAT in a multi vendor environment is limite...

    Authors: Judith Alvarez-Moret, Fabian Pohl, Oliver Koelbl and Barbara Dobler
    Citation: Radiation Oncology 2010 5:110
  40. The phosphatidylinositol-3-kinase (PI3K)/Akt pathway is frequently deregulated in prostate cancer and associated with neoplastic transformation, malignant progression, and enhanced resistance to classical chem...

    Authors: Justine Rudner, Carola-Ellen Ruiner, René Handrick, Hans-Jörg Eibl, Claus Belka and Verena Jendrossek
    Citation: Radiation Oncology 2010 5:108
  41. We have shown that the radio sensitizer DCQ enhances sensitivity of HCT116 human colon cancer cells to hypoxia. However, it is not known whether the p53 or p21 genes influence cellular response to DCQ. In this...

    Authors: Mona El-Khatib, Fady Geara, Makhluf J Haddadin and Hala Gali-Muhtasib
    Citation: Radiation Oncology 2010 5:107
  42. A study was performed to assess dosimetric characteristics of volumetric modulated arcs (RapidArc, RA) and fixed field intensity modulated therapy (IMRT) for Whole Abdomen Radiotherapy (WAR) after ovarian cancer.

    Authors: Umesh Mahantshetty, Swamidas Jamema, Reena Engineer, Deepak Deshpande, Rajiv Sarin, Antonella Fogliata, Giorgia Nicolini, Alessandro Clivio, Eugenio Vanetti, Shyamkishore Shrivastava and Luca Cozzi
    Citation: Radiation Oncology 2010 5:106

Annual Journal Metrics

  • 2022 Citation Impact
    3.6 - 2-year Impact Factor
    3.8 - 5-year Impact Factor
    1.370 - SNIP (Source Normalized Impact per Paper)
    1.037 - SJR (SCImago Journal Rank)

    2023 Speed
    16 days submission to first editorial decision for all manuscripts (Median)
    132 days submission to accept (Median)

    2023 Usage 
    1,958,690 downloads
    605 Altmetric mentions